HIV-Antigens Charged on Phosphorus Dendrimers as Tools for Tolerogenic Dendritic Cells-Based Immunotherapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|16|1898-1909

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.16, 2014-05, pp. : 1898-1909

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel activators of dendritic cells as fundamental tools in immunotherapy

By Gallucci Stefania  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 9, 2001-09 ,pp. : 1411-1421

Informa Healthcare

Access to resources Recommend Favorite

Regulatory T Cells and Tolerogenic Dendritic Cells as Critical Immune Modulators in Atherogenesis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 9, 2015-03 ,pp. : 1107-1117

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic Cells in Tumor Immunology and Immunotherapy

By  

Current Drug Targets, Vol. 5, Iss. 1, 2004-01 ,pp. : 17-39

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic cells: immunological features and utilisation for tumour immunotherapy

By Reay Philip A  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 4, 2001-08 ,pp. : 491-506

Informa Healthcare

Access to resources Recommend Favorite

Genetically Modified Dendritic Cells for Cancer Immunotherapy

By  

Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. : 619-628

Bentham Science Publishers

Access to resources Recommend Favorite